scholarly journals Transvaginal surgery using self‐cut mesh for pelvic organ prolapse: 3‐year clinical outcomes

2019 ◽  
Vol 26 (7) ◽  
pp. 731-736 ◽  
Author(s):  
Sheryl Ghia Gonocruz ◽  
Tokumasa Hayashi ◽  
Shino Tokiwa ◽  
Yugo Sawada ◽  
Yoshiyuki Okada ◽  
...  
2017 ◽  
Vol 108 (3) ◽  
pp. 137-144
Author(s):  
Shingo Moriyama ◽  
Ting-wen Huang ◽  
Kriengkrai Sittidilokratna ◽  
Bahiyah Abdullah ◽  
Shino Tokiwa ◽  
...  

Author(s):  
Hirotaka Sato ◽  
Hirokazu Abe ◽  
Atsushi Ikeda ◽  
Tomoaki Miyagawa ◽  
Katsuhiko Sato

2021 ◽  
Vol 28 (2) ◽  
pp. 216-219
Author(s):  
Yugo Sawada ◽  
Yasuhide Kitagawa ◽  
Tokumasa Hayashi ◽  
Shino Tokiwa ◽  
Mika Nagae ◽  
...  

Author(s):  
Georgios Poutakidis ◽  
Anna Marsk ◽  
Daniel Altman ◽  
Christian Falconer ◽  
Edward Morcos

Abstract Introduction and hypothesis Vaginal prolapse mesh may effectively restore vaginal anatomy. The aim of this study was to investigate how the in vivo mesh position correlates to clinical outcomes. Methods Seventy-one women operated on using Uphold mesh for apical pelvic organ prolapse (POP-Q, C ≥ stage II) were examined 5 years after surgery by introital-perineal 2D ultrasound in a midsagittal plane at rest and Valsalva. The horizontal line and pubis symphysis were considered the reference for all measures. Ultrasound measures were statistically compared to clinical outcomes: POP-Q, Pelvic Floor Distress Inventory (PFDI-20) and subscales [Pelvic Organ Distress Inventory (PODI-6), and Urinary Distress Inventory (UDI-6)] and the VAS scale for pain. Results Original mesh length was preserved by 86% and correlated to improved pain as estimated by VAS scale (r 0.321). Valsalva was associated with a lowering of the superior and inferior mesh margins by 7.3 and 6.1 mm, respectively (p < 0.001) but a reduction of total mesh length by only 1 mm (30.2 ± 5.2 to 29.2 ± 4.7 mm, p < 0.001). Mobility of the anterior vaginal wall (bladder neck and midurethra) at Valsalva was parallel to downward movement of the mesh inferior margin (r 0.346 and 0.314) but inversely correlated to total UDI-6 (r − 0.254 and − 0.263). Mobility of the midurethra was inversely correlated to bladder emptying (PFDI-20 Question 19, r − 0.245). Conclusions Five years after surgery, preserved original length of the mesh with apical support was correlated to improved anatomical and patient-reported outcomes. Mesh support to the vaginal apex was associated with improved bladder emptying and total urinary distress outcomes but not stress urinary incontinence.


2014 ◽  
Vol 21 (5) ◽  
pp. 753-761 ◽  
Author(s):  
Tsia-Shu Lo ◽  
Yiap Loong Tan ◽  
Siwatchaya Khanuengkitkong ◽  
Anil Krishna Dass ◽  
Eileen Feliz M. Cortes ◽  
...  

2015 ◽  
Vol 2015 ◽  
pp. 1-9 ◽  
Author(s):  
Ting-Chen Chang ◽  
Sheng-Mou Hsiao ◽  
Chi-Hau Chen ◽  
Wen-Yih Wu ◽  
Ho-Hsiung Lin

Objective. To evaluate the clinical outcomes and urodynamic effects of tailored anterior transvaginal mesh surgery (ATVM) and tailored posterior transvaginal mesh surgery (PTVM).Methods. We developed ATVM for the simultaneous correction of cystocele and stress urinary incontinence and PTVM for the simultaneous correction of enterocoele, uterine prolapse, vaginal stump prolapse, and rectocele.Results. A total of 104 women enrolled. The median postsurgical follow-up was 25.5 months. The anatomic cure rate was 98.1% (102/104). Fifty-eight patients underwent urodynamic studies before and after surgeries. The pad weight decreased from 29.3 ± 43.1 to 6.4 ± 20.9 g at 3 months. Among the 20 patients with ATVM, 13 patients had objective stress urinary incontinence (SUI) at baseline while 8 patients came to have no demonstrated SUI (NDSUI), and 2 improved after surgery. Among the 38 patients who underwent ATVM and PTVM, 24 had objective SUI at baseline while 18 came to have NDSUI, and 2 improved after surgery. Mesh extrusion (n= 4), vaginal hematoma (n= 3), and voiding difficulty (n= 2) were noted postoperatively. Quality of life was substantially improved.Conclusions. Our findings document the advantages of these two novel pelvic reconstructive surgeries for pelvic organ prolapse, which had a positive impact on quality of life. ATVM surgery additionally provided an anti-incontinence effect. This clinical trial is registered at ClinicalTrials.gov (NCT02178735).


Sign in / Sign up

Export Citation Format

Share Document